Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kees Hovingh"'
Autor:
Jordan M. Kraaijenhof, Héléne T. Cronjé, G. Kees Hovingh, Nick S. Nurmohamed, Dipender Gill, Loukas Zagkos
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Externí odkaz:
https://doaj.org/article/ce4afd7541434e509f54df4e4fe15723
Autor:
Shirin Ibrahim, Nick S. Nurmohamed, Didier Collard, Anouk de Weger, G. Kees Hovingh, Bert‐Jan H. van den Born, Laurens F. Reeskamp, Erik S. G. Stroes, Tom F. Brouwer
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 22 (2023)
Background Medication nonadherence contributes to poor health outcomes but remains challenging to identify. This study assessed the association between self‐rated adherence and systolic blood pressure, low‐density lipoprotein cholesterol levels,
Externí odkaz:
https://doaj.org/article/5518a4fd1e424e2bbc5c5fd76e2a17e4
Autor:
Jordan M. Kraaijenhof, Tycho R. Tromp, Nick S. Nurmohamed, Laurens F. Reeskamp, Marije Langenkamp, Johannes H. M. Levels, S. Matthijs Boekholdt, Nicholas J. Wareham, Menno Hoekstra, Erik S. G. Stroes, G. Kees Hovingh, Aldo Grefhorst
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 21 (2023)
Background ANGPTL3 (angiopoietin‐like protein 3) is an acknowledged crucial regulator of lipid metabolism by virtue of its inhibitory effect on lipoprotein lipase and endothelial lipase. It is currently unknown whether and to which lipoproteins ANG
Externí odkaz:
https://doaj.org/article/bafeced5a2c34d4aab76891c406e105f
Autor:
null Darren K. McGuire, null Rodica P. Busui, null John Deanfield, null Silvio E. Inzucchi, null Johannes F. E. Mann, null Nikolaus Marx, null Sharon L. Mulvagh, null Neil Poulter, null Mads D. M. Engelmann, null G. Kees Hovingh, null Maria Sejersten Ripa, null Mette Gislum, null Kirstine Brown‐Frandsen, null John B. Buse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd3795aafb68164a517c289f6e7d0993
https://doi.org/10.1111/dom.15058/v2/response1
https://doi.org/10.1111/dom.15058/v2/response1
Autor:
Liffert Vogt, Sripal Bangalore, Rana Fayyad, Shari Melamed, G. Kees Hovingh, David A. DeMicco, David D. Waters
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 9 (2019)
Background Kidney function decreases during the lifetime, and this decline is a powerful predictor of both kidney and cardiovascular outcomes. Statins lower cardiovascular risk, which may relate to beneficial effects on kidney function. We studied wh
Externí odkaz:
https://doaj.org/article/0257b1f7ed234bc98c40d14792a31da0
Autor:
Arjen J, Cupido, Folkert W, Asselbergs, Pradeep, Natarajan, Paul M, Ridker, G Kees, Hovingh, A Floriaan, Schmidt
Publikováno v:
British journal of clinical pharmacology, 88(6), 2875-2884. Wiley-Blackwell
AIMS: Chronic inflammation is a risk factor for cardiovascular disease (CVD). IL-6 signalling perturbation through IL-6 or IL-6R blockade may have potential benefit on cardiovascular risk. It is unknown whether targeting either IL-6 or IL-6 receptor
Autor:
Julian C. van Capelleveen, Andrea E. Bochem, S. Matthijs Boekholdt, Samia Mora, Ron C. Hoogeveen, Christie M. Ballantyne, Paul M Ridker, Wensheng Sun, Philip J. Barter, Alan R. Tall, Aeilko H. Zwinderman, John J. P. Kastelein, Nick J. Wareham, Kay‐Tee Khaw, G. Kees Hovingh
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 8 (2017)
BackgroundThe contribution of apolipoprotein A‐I (apoA‐I) to coronary heart disease (CHD) risk stratification over and above high‐density lipoprotein cholesterol (HDL‐C) is unclear. We studied the associations between plasma levels of HDL‐C
Externí odkaz:
https://doaj.org/article/3670d413f04b444b99bb4c8cbffc9cae
Autor:
G. Kees Hovingh, Erik S.G. Stroes, David Kallend, Darren Bentley, Eric J. Niesor, John J.P. Kastelein
Publikováno v:
Lipids, 49(12), 1245-1249. Springer Verlag
We investigated the effect of dalcetrapib treatment on phytosterol levels in patients with familial combined hyperlipidemia (FCH) or familial hypoalphalipoproteinemia (FHA) due to mutations in apolipoprotein A1 (ApoA1) or ATP-binding cassette transpo
Autor:
Jan Albert Kuivenhoven, Mats Lindahl, Adriaan G. Holleboom, Johannes H.M. Levels, Sofie C. Sundberg, Andrea E. Bochem, Kees Hovingh, Stefan Ljunggren, Maria V. Turkina, Helen Karlsson
Publikováno v:
Proteomics. Clinical Applications, 8(3-4), 241-250. WILEY-V C H VERLAG GMBH
Proteomics. Clinical applications, 8(3-4), 241-250. Wiley-VCH Verlag
Proteomics. Clinical applications, 8(3-4), 241-250. Wiley-VCH Verlag
PurposeMutations in apolipoprotein A-I (apoA-I) may affect plasma high-density lipoprotein (HDL) cholesterol levels and the risk for cardiovascular disease but little is known about the presence and effects of circulating apoA-I variants. This study
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 12 (2022)
Background Epidemiological studies show that women are generally at lower risk for cardiovascular disease than men. Here, we investigated the sex‐specific differential effect of genetically increased low‐density lipoprotein cholesterol (LDL‐C)
Externí odkaz:
https://doaj.org/article/61fce86dbfff44e9862cff31c85dc4ae